Northwest Biotherapeutics, Inc. (NWBO) - Stock Prices, Stock Peers & Analysis

Home
NWBO

Company Name	Northwest Biotherapeutics, Inc.
Symbol	NWBO
Currency	USD
Price	0.823
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	957,167,047
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.4 - 1.27
Industry	Biotechnology
Sector	Healthcare
CEO	Ms. Linda F. Powers J.D.
Website	https://www.nwbio.com

An error occurred while fetching data.

About Northwest Biotherapeutics, Inc.

Northwest Biotherapeutics, Inc., a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient's own immune system to attack cancer. Its lead product, DCVax-L, which has